Graham Corporation logo GHM - Graham Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 3
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $132.50 DETAILS
HIGH: $135.00
LOW: $130.00
MEDIAN: $132.50
CONSENSUS: $132.50
UPSIDE: 58.70%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 40% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Strong
Trading 231.3% above fair value
Current Price $83.49
Bear Case $20.16 75.9% downside ($20.16 - $83.49) / $83.49 = -75.9% $1.12 × 18x P/E
Fair Value $25.20 69.8% downside ($25.20 - $83.49) / $83.49 = -69.8% $1.12 × 22x P/E
Bull Case $30.24 63.8% downside ($30.24 - $83.49) / $83.49 = -63.8% $1.12 × 27x P/E

Adjust Assumptions

22.5x
1.12$

Key Value Driver

Normalized P/E multiple (22x base case)

Implied Market Multiple 74.5x

Plain-Language Summary

Applying a 22x P/E to adjusted EPS of $1.12, the base-case value is $25.20 per share. DDM cross-check: $11.73.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (6 analysts) $132.50
Analyst Range $130.00 – $135.00
Divergence from AlphaVal 81%

Warnings

Dividend-based valuation: $11.73 (below our primary estimate by 53%). Large gaps may signal the dividend doesn't reflect full earning power.
Wall Street's average price target is $132.50 (from 6 analysts). Our estimate is 81% below the consensus -- consider that gap carefully.

Key Risks

  • Growth DCF inappropriate — terminal value assumptions dominate
  • EV/EBITDA misleading for regulated businesses where capex is mandated
  • Regulatory risk is a fat tail not visible in normal multiples